See you next year! September 15-18, 2025
Hynes Convention CenterBoston, MAPreliminary Conference Agenda
Enabling Greater Success of Cell Therapy Commercialization
Hari Kamaraju, MS, MBA, Senior Scientist, Janssen Research & Development.
Advances in CAR T Cell Manufacturing
Isabelle Riviere, Ph.D., Director, Michael G. Harris Cell Therapy and Cell Engineering Facility, Molecular Pharmacology, Memorial Sloan Kettering Cancer Center
Process Development and Optimization in 3D Packed Bed Bioreactor Systems for Ensuring Successful Launch into Marketing Scale Manufacturing
Lior Raviv, Vice President of Development, Pluristem Therapeutics
Aseptic Processing Strategy for Cell Based Product Manufacturing
Julie Zhu, Ph.D., Associate Director, Janssen Pharmaceuticals
The Development of Animal-Component-Free, Chemically-De ned Culture Media for Immune Cells
Jessie Ni, Ph.D., Chief Scientific Officer, Irvine Scientific
Preliminary Workshop Agenda
Cell Based Immunotherapies: One Day Course
David Brindley, DPhil, MEng, FRSA Managing Partner, Biolacuna & Senior Research Fellow, Nuf eld Department of Paediatrics, University of Oxford, United Kingdom
Pre-Conference Symposia
Monday, September 25, 2017
- Continuous Processing
- Vaccine Development and Production: Novel Technologies and Strategies
- Biosimilar Development and Production
- Modern CMC Regulatory Strategies and Insights
- Advanced Control Strategies in Bioprocessing and Biomanufacturing: Disruptive Technologies and Emerging Platforms for Biologics Facilities of the Future
- Cell-Based Immunotherapies